CasLoc logo
All Cases PTAB Litigations UPC Oppositions

TEVA WOMEN'S HEALTH, INC. v. WATSON LABORATORIES, INC.

2:10-cv-02061

Overview

Case Number 2:10-cv-02061
Filing Date 2010-04-23
Status Terminated
Termination Date 2011-10-13
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

WATSON LABORATORIES, INC. Operating Company

Represented By

2 Attorneys Listed

Consol Defendant

WATSON PHARMACEUTICALS, INC. Operating Company

Represented By

2 Attorneys Listed

Counter Defendant

TEVA WOMEN'S HEALTH, INC. Operating Company

Represented By

1 Attorneys Listed

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): πŸ‡¨πŸ‡¦ Canada CN πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5908638
Pharmaceutical compositions of conjugated estrogens and methods for their use
Filed: 1996-07-25
Issued: 1999-06-01
Expired (Term Ended)
Expires: 2016-07-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

2

Denied

0

Pending / Review

0

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Granted
ORDER granting 17 Motion for Leave to Appear Pro Hac Vice re: Michael H. Baniak, Gary E. Hood, Nicole E. Reifman. Signed by Magistrate Judge Claire C. Cecchi on...
Entry #18 • 2010-09-07 Document →
Procedural / Extension Motion Granted
MOTION for Leave to Appear Pro Hac Vice by WATSON LABORATORIES, INC., WATSON PHARMACEUTICALS, INC.. (Attachments: # 1 Statement in Lieu of Brief, # 2 Certificat...
Entry #17 • 2010-08-02 Document →

Docket Entries

(42 total)
Pleading / Complaint

COMPLAINT against WATSON LABORATORIES, INC., WATSON PHARMACEUTICALS, INC. ( Filing fee $ 350 receipt number 3080811.) None., filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 Certificate of Non-Arbitrability, # 2 Civil Cover Sheet)(ld, ) (Entered: 04/26/2010)

Entry #1 • 2010-04-23
1
Pleading / Complaint

COMPLAINT against WATSON LABORATORIES, INC., WATSON PHARMACEUTICALS, INC. ( Filing fee $ 350 receipt number 3080811.) None., filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 Certificate of Non-Arbitrability, # 2 Civil Cover Sheet)(ld, ) (Entered: 04/26/2010)

Entry #1 • 2010-04-23
2
Pleading / Complaint

COMPLAINT against WATSON LABORATORIES, INC., WATSON PHARMACEUTICALS, INC. ( Filing fee $ 350 receipt number 3080811.) None., filed by TEVA WOMEN'S HEALTH, INC.. (Attachments: # 1 Certificate of Non-Arbitrability, # 2 Civil Cover Sheet)(ld, ) (Entered: 04/26/2010)

Entry #1 • 2010-04-23
2

Corporate Disclosure Statement by TEVA WOMEN'S HEALTH, INC. identifying Barr Pharmaceuticals, LLC as Corporate Parent.. (ld, ) (Entered: 04/26/2010)

Entry #2 • 2010-04-23
1

SUMMONS ISSUED as to WATSON LABORATORIES, INC., WATSON PHARMACEUTICALS, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Leroy Dunbar* (ld, ) (Entered: 04/26/2010)

Entry #3 • 2010-04-26
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc